These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9211494)

  • 121. Post-meal endogenous insulin secretion was significantly lower in head than in body/tail cancer of the pancreas.
    Shichijo H; Hosaka T; Takewaki F; Sumitani Y; Ishida H; Yasuda K
    J Med Invest; 2023; 70(3.4):350-354. PubMed ID: 37940518
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Glucagon, the hyperglycemic agent in pancreatic extracts; a possible factor in certain types of diabetes.
    PINCUS IJ; RUTMAN JZ
    AMA Arch Intern Med; 1953 Nov; 92(5):666-77. PubMed ID: 13091483
    [No Abstract]   [Full Text] [Related]  

  • 123. Comparison between changes in serum inorganic phosphorus induced by glucose and glucagon in diabetics.
    DE VENANZI F
    Proc Soc Exp Biol Med; 1955 Oct; 90(1):112-5. PubMed ID: 13273370
    [No Abstract]   [Full Text] [Related]  

  • 124. Increased alpha cell to beta cell ratio in patients with pancreatic cancer.
    Tsuchiya T; Saisho Y; Inaishi J; Sasaki H; Sato M; Nishikawa M; Masugi Y; Yamada T; Itoh H
    Endocr J; 2022 Dec; 69(12):1407-1414. PubMed ID: 35934795
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Metabolic perioperative management: novel concepts.
    Ljungqvist O; Nygren J; Soop M; Thorell A
    Curr Opin Crit Care; 2005 Aug; 11(4):295-9. PubMed ID: 16015105
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Pancreatic and gut hormones as predictors of new-onset prediabetes after non-necrotising acute pancreatitis: a prospective longitudinal cohort study.
    Bharmal SH; Kimita W; Ko J; Petrov MS
    Endocr Connect; 2021 Jun; 10(7):715-724. PubMed ID: 34097643
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Effect of glucagon in stable and unstable diabetic patients.
    KIRTLEY WR; WAIFE SO; PECK FB
    Proc Soc Exp Biol Med; 1953 Jun; 83(2):387-9. PubMed ID: 13064278
    [No Abstract]   [Full Text] [Related]  

  • 128. [New-onset diabetes as an early sign of pancreatic cancer].
    Ahn J; Lee JK
    Korean J Gastroenterol; 2013 Nov; 62(5):263-6. PubMed ID: 24262590
    [TBL] [Abstract][Full Text] [Related]  

  • 129. The polypeptide hormone-derived amyloid forms: nonspecific alterations or signs of abnormal peptide-processing?
    Westermark P; Johnson KH
    APMIS; 1988 Jun; 96(6):475-83. PubMed ID: 3293625
    [No Abstract]   [Full Text] [Related]  

  • 130. Hyperglycemia as a risk factor in pancreatic cancer: A nested case-control study using prediagnostic blood glucose levels.
    Jacobson S; Dahlqvist P; Johansson M; Svensson J; Billing O; Sund M; Franklin O
    Pancreatology; 2021 May; ():. PubMed ID: 34049822
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men.
    Smith GD; Egger M; Shipley MJ; Marmot MG
    Am J Epidemiol; 1992 Nov; 136(9):1110-4. PubMed ID: 1462971
    [TBL] [Abstract][Full Text] [Related]  

  • 132. The relationship between diabetes and pancreatic cancer.
    Wang F; Herrington M; Larsson J; Permert J
    Mol Cancer; 2003 Jan; 2():4. PubMed ID: 12556242
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Diabetes Type 2 and Pancreatic Cancer: A History Unfolding.
    De Souza A; Irfan K; Masud F; Saif MW
    JOP; 2016 Mar; 17(2):144-148. PubMed ID: 29568247
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Sodium transport in diabetes: two sides to the coin.
    Lovshin JA; Cherney DZ
    Nat Rev Nephrol; 2019 Mar; 15(3):125-126. PubMed ID: 30580375
    [No Abstract]   [Full Text] [Related]  

  • 135. Weight Loss With Rising Blood Glucose: Challenges in Distinguishing Conventional Type 2 Diabetes From Pancreatic Cancer-Associated Hyperglycemia.
    Johannes L; Westcott GP
    Clin Diabetes; 2023; 41(3):477-480. PubMed ID: 37456104
    [No Abstract]   [Full Text] [Related]  

  • 136. Heparanase contributes to pancreatic carcinoma progression through insulin-dependent glucose uptake.
    Abecassis A; Hermano E; Yifrach A; Popovtzer A; Meirovitz A; Elkin M
    Front Cell Dev Biol; 2023; 11():1287084. PubMed ID: 38078007
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Usefulness of Practitioner-Led Pancreatic Cancer Screening.
    Matsumoto K; Kushiyama Y; Izumi A; Ohnishi K; Miura M; Ohuchi Y; Hori I; Nakamura T; Hori K; Koshino K; Kobayashi J; Yoshino N; Hoshino U; Okumura T; Tanimura T; Tanaka S; Tanaka S; Nabika T; Nozu T; Wakatsuki Y; Katayama S; Yoshioka S; Ito K; Uchida A; Yuhara N; Noma H; Isomoto H
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140658
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Role of Pancreatic Stellate Cell-Derived Exosomes in Pancreatic Cancer-Related Diabetes: A Novel Hypothesis.
    Perera CJ; Falasca M; Chari ST; Greenfield JR; Xu Z; Pirola RC; Wilson JS; Apte MV
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680372
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.
    Hart PA; Bellin MD; Andersen DK; Bradley D; Cruz-Monserrate Z; Forsmark CE; Goodarzi MO; Habtezion A; Korc M; Kudva YC; Pandol SJ; Yadav D; Chari ST;
    Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):226-237. PubMed ID: 28404095
    [TBL] [Abstract][Full Text] [Related]  

  • 140. High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening.
    Bruenderman EH; Martin RC
    J Surg Res; 2015 Mar; 194(1):212-9. PubMed ID: 25479908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.